- Home
- CRT vs UG Comparison
CRT vs UG Comparison
Compare CRT & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- UG
- Stock Information
- Founded
- CRT 1991
- UG 1942
- Country
- CRT United States
- UG United States
- Employees
- CRT N/A
- UG N/A
- Industry
- CRT Oil & Gas Production
- UG Package Goods/Cosmetics
- Sector
- CRT Energy
- UG Consumer Discretionary
- Exchange
- CRT Nasdaq
- UG Nasdaq
- Market Cap
- CRT 45.2M
- UG 36.4M
- IPO Year
- CRT 1992
- UG N/A
- Fundamental
- Price
- CRT $7.11
- UG $7.55
- Analyst Decision
- CRT
- UG
- Analyst Count
- CRT 0
- UG 0
- Target Price
- CRT N/A
- UG N/A
- AVG Volume (30 Days)
- CRT 27.3K
- UG 7.4K
- Earning Date
- CRT 01-01-0001
- UG 11-07-2025
- Dividend Yield
- CRT 10.37%
- UG 9.27%
- EPS Growth
- CRT N/A
- UG N/A
- EPS
- CRT 0.92
- UG 0.56
- Revenue
- CRT $6,559,820.00
- UG $10,856,174.00
- Revenue This Year
- CRT N/A
- UG N/A
- Revenue Next Year
- CRT N/A
- UG N/A
- P/E Ratio
- CRT $7.78
- UG $13.57
- Revenue Growth
- CRT N/A
- UG N/A
- 52 Week Low
- CRT $7.12
- UG $7.25
- 52 Week High
- CRT $13.31
- UG $14.85
- Technical
- Relative Strength Index (RSI)
- CRT 27.77
- UG 44.22
- Support Level
- CRT $7.38
- UG $7.36
- Resistance Level
- CRT $7.72
- UG $7.70
- Average True Range (ATR)
- CRT 0.18
- UG 0.17
- MACD
- CRT -0.00
- UG 0.01
- Stochastic Oscillator
- CRT 5.88
- UG 26.03
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.